Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1) : 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
- Submitting institution
-
University of Dundee
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 28403801
- Type
- D - Journal article
- DOI
-
10.1016/S2213-8587(17)30308-X
- Title of journal
- The Lancet: Diabetes and Endocrinology
- Article number
- -
- First page
- 864
- Volume
- 5
- Issue
- 11
- ISSN
- 2213-8587
- Open access status
- Not compliant
- Month of publication
- September
- Year of publication
- 2017
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
10
- Research group(s)
-
-
- Citation count
- 145
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -